Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Dysregulation of innate and adaptive immunity in patients with atopic dermatitis: Impact of IL-31/IL-31R & staphylococcal α-toxin Sadaf Kasraie, Ph.D. Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy Activation IL-31/IL-31R CD 4+ T- Cells Induces pro-inflammatory cytokines in some human cell lines so far 1,2 (24 KDa) Receptor 1: IL-31RA (GPL) (120 KDa) Receptor 2: OSMR (180 KDa) Epithelial cells Keratinocytes Jak/STAT, PI3 kinase/Akt and MAP kinase signalling pathway Sadaf Kasraie Division of Immunodermatology and Allergy Research Activated monocytes and macrophages Eosinophils 1 Dambacher J. et al. 2007. Gut 56:257-65. Modified from Le Saux S. et al. J Biol Chem. 2010. 285:3470-7 2 Yagi Y. et al. 2007. Int J Mol Med 19:941-6. Role of IL-31 IL-31 overexpression may lead to : • Pruritus • Alopecia • Skin lesions • Airway hypersensitivity • Atopic dermatitis (atopic eczema) • Allergy Sadaf Kasraie Division of Immunodermatology and Allergy Research Review • Transgenic overexpression of IL-31 in lymphocytes induces severe pruritus in mice (Dillon et al., Nat Immunol 2004). • IL-31 is overexpressed in the skin of patients with atopic dermatitis (Sonkoly et al., JACI 2006). • Serum IL-31 levels are significantly higher in patients with AD and correlated with disease activity in AD (Raap et al., JACI 2008). • Staphylococcal superantigens rapidly induce IL-31 expression in atopic individuals in vivo and in leukocytes in vitro (Sonkoly et al., JACI 2006). Sadaf Kasraie Division of Immunodermatology and Allergy Research Approach To investigate • the expression, • the regulation of IL-31R, • functional effects of IL-31 in human primary cells (monocytes, macrophages, keratinocytes and eosinophils): Regulation of STAT and MAPK signalling pathways as well as cytokine secretion Sadaf Kasraie Division of Immunodermatology and Allergy Research Expression of IL-31RA on Immune Cells & Keratinocytes Non Stimulated Stimulated* Monocytes - ++1,2 Macrophages - ++1,2 DC: moDC - - DC: IDEC - - Lymphocytes - - Keratinocytes +3 ++ Eosinophils +4 + 1 Kasraie S. et al. 2010. Allergy. 65:712–721. 2 Kasraie S. et al. 2011. Allergy. 66:845-52. 3 Kasraie S. et al. 2013. Allergy. 68:739-47. 4 Raap U, Gehring M, Kasraie S. et al. Submitted. Sadaf Kasraie Division of Immunodermatology and Allergy Research * SEB, α-toxin or TLR-2 agonists Macrophages Kasraie and Werfel. 2013. Mediators Inflamm 2013:942375 Modified from Werfel T. 2009. J Invest Dermatol 129:1878-91 Sadaf Kasraie Division of Immunodermatology and Allergy Research Staphylococcal exotoxins significantly up-regulate IL-31RA expression in human monocytes and macrophages at the mRNA level A) Monocytes Sadaf Kasraie Division of Immunodermatology and Allergy Research B) Macrophages Staphylococcal exotoxins exotoxins up-regulate up-regulate IL-31RA IL-31RA Staphylococcal expression in human monocytes and at the expression in human monocytes atmacrophages the protein level protein level A) Monocytes Sadaf Kasraie Division of Immunodermatology and Allergy Research B) Macrophages Signalling pathways of IL-31 in human macrophages pSTAT-1 β-actin pSTAT-5 β-actin pERK1/2 β-actin Sadaf Kasraie Division of Immunodermatology and Allergy Research Summary of IL-31 effects upon staphylococcal exotoxins stimulation in monocytes & macrophages Cells Cytokine MΦ & PBMCs IL-6 MΦ & PBMCs IL-1β MΦ IL-18 MΦ IL-8 MΦ IL-10 MΦ TNF-α MΦ MIP-1α MΦ MCP-1α MΦ IL-12p40 MΦ IL-12p70 MΦ IL-23p19/p40 Sadaf Kasraie Division of Immunodermatology and Allergy Research SEB α-toxin IL-31 induces pro-inflammatory cytokines in human macrophages following up-regulation of the IL-31R with staphylococcal exotoxins Sadaf Kasraie Division of Immunodermatology and Allergy Research IL-31 down-regulates IL-12 in human macrophages following up-regulation of the IL-31R with staphylococcal exotoxins Sadaf Kasraie Division of Immunodermatology and Allergy Research Keratinocytes Kasraie and Werfel. 2013. Mediators Inflamm 2013:942375 Modified from Werfel T. 2009. J Invest Dermatol 129:1878-91 Sadaf Kasraie Division of Immunodermatology and Allergy Research TLR-2 ligand Pam3Cys up-regulates IL-31RA expression in human primary keratinocytes at the mRNA level * *Pam3Cys-SK4: N-Palmitoyl-S-[2,3-bis (palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysine Sadaf Kasraie Division of Immunodermatology and Allergy Research Pam3Cys or IFN-γ up-regulates IL-31R expression on human primary keratinocytes at the protein level NS= Not Stimulated Sadaf Kasraie Division of Immunodermatology and Allergy Research Signalling pathway of IL-31 in human keratinocytes pSTAT-3 STAT-3 Sadaf Kasraie Division of Immunodermatology and Allergy Research Summary of IL-31 effects upon Pam3Cys or IFN-γ stimulation in keratinocytes HPKs Chemokine/Cytokine Pam3cys IFN-γ Foreskin & Hair CCL2 + + Foreskin VEGF + - Foreskin CCL22 + - Foreskin CCL20 - - Foreskin EGF Foreskin MMP-9 Foreskin & Hair IL-1β - - Foreskin & Hair IL-6 - - Foreskin & Hair IL-8 - - Sadaf Kasraie Division of Immunodermatology and Allergy Research IL-31 induces CCL2 secretion in human primary keratinocytes following up-regulation of the IL-31R with Pam3Cys or IFN-γ Sadaf Kasraie Division of Immunodermatology and Allergy Research IL-31 Staphylococcal exotoxins TLR-2 ligands or IFN-γ Activated monocytes and macrophages STAT-1/5, ERK1/2 pro-inflammatory cytokines (IL-1β, IL-6, IL-18) Sadaf Kasraie Division of Immunodermatology and Allergy Research Eosinophils Keratinocytes STAT-3 CCL2, VEGF STAT-3, ERK1/2 CCL26, release of superoxide species Atopic dermatitis (AD) vs healthy controls (HC) Patient 1 with AD Sadaf Kasraie Division of Immunodermatology and Allergy Research Patient 2 with AD IFN-γ leads to significantly higher of IL-31RA IL-31 induces greater levels of expression IL-1β secretion in on monocytes from patients compared to monocytes from patients withwith AD AD compared to HC healthy controls (HC) Sadaf Kasraie Division of Immunodermatology and Allergy Research Pam3Cys up-regulates expression IL-31 induced lower levelsIL-31RA of CCL2 secretion in keratinocytes bothwith fromAD ADcompared and HC to HC keratinocytes from patients Sadaf Kasraie Division of Immunodermatology and Allergy Research Impaired TLR-2 expression in keratinocytes from inflamed AD skin compared with healthy controls Sadaf Kasraie Division of Immunodermatology and Allergy Research Conclusion IL-31 IL-31 Homey et al. 2006. J Allergy Clin Immunol. Review. • • • • The Th2 cytokine IL-31 induces itch. IL-31 has inflammatory properties. The IL-31R is expressed on immune cells and keratinocytes. The IL-31R is regulated by staphylococcal-derived molecules. Sadaf Kasraie Division of Immunodermatology and Allergy Research Conclusion & Outlook • Evidence for a functional role of IL-31 on human eosinophils. • Novel implications for treatment options in eosinophil associated diseases including AD. • Colonization with S. aureus and presence of IL-31 in the skin may represent important trigger factors in the complex amplification cycle of atopic skin inflammation. • Antiseptic strategies as well as targeting IL-31 and its receptor in atopic individuals may represent useful tools to support the therapeutic management of patients suffering from AD. Sadaf Kasraie Division of Immunodermatology and Allergy Research Acknowledgment Ulrike Raap Margarete Niebuhr Kathrin Baumert Gabriele Begemann Maria Gschwandtner Manuela Gehring Jana Zeitvogel Christina Hartmann Hari Balaji Susanne Mommert Susanne Hradetzky Thomas Werfel Armin Braun Wolfgang Baeumer All members of the Dept. of Dermatology & Allergy Family! Sadaf Kasraie Division of Immunodermatology and Allergy Research Acknowledgment Ulrike Raap Margarete Niebuhr Kathrin Baumert Gabriele Begemann Maria Gschwandtner Manuela Gehring Jana Zeitvogel Christina Hartmann Hari Balaji Susanne Mommert Susanne Hradetzky Thomas Werfel Armin Braun Wolfgang Baeumer All members of the Dept. of Dermatology & Allergy Family! Sadaf Kasraie Division of Immunodermatology and Allergy Research RE Schmidt Susanne Kruse Marlies Daniel Sadaf Kasraie Division of Immunodermatology and Allergy Research HBRS et al. 2010. MHH info. Overview Atopic Dermatitis (atopic eczema) is a chronically relapsing inflammatory skin disease Prevelance: 10 to 20% in children and 1% to 3% in adults Causes: Although it is such a common disease, the immunopathogenesis is not completely understood Sadaf Kasraie Division of Immunodermatology and Allergy Research Trigger factors in Atopic Dermatitis Food allergens Hormones & related Factors Autoantigens Irritable substances Skin colonizing microorganisms Genetic background Inhalant allergens Environment Psychological stress Werfel et Sadaf Kasraie Division of Immunodermatology and Allergy Research Werfel et al. Leitline Atopisches Ekzem www.awmf.de 2002 (Revision 2007) al. HTA Bericht Neurodermitis www.egms.de 2006 IL-31 induces IL-12 suppression via ERK 1/2 phosphorylation in human macrophages following up-regulation of the IL-31R with staphylococcal exotoxins Sadaf Kasraie Division of Immunodermatology and Allergy Research Eosinophils Modified from Werfel T. 2009. J Invest Dermatol 129:1878-91 Sadaf Kasraie Division of Immunodermatology and Allergy Research Human eosinophils express the IL-31RA A) At the mRNA level Sadaf Kasraie Division of Immunodermatology and Allergy Research B) At the protein level Signalling pathways of IL-31 in human eosinophils pSTAT-3 pERK1/2 STAT-3 Sadaf Kasraie Division of Immunodermatology and Allergy Research ERK1/2 Human eosinophils are activated by IL-31 with release of CCL26 and reactive oxygen species Sadaf Kasraie Division of Immunodermatology and Allergy Research Functional effect of IL-31 in eosinophils 220,00 4 3.0 *** 200,00 180,00 * ** ** 1.5 ** 0.0 Fluorescence intensity Chemotactic Index 12 Medium 160,00 IL31 100ng IL31 100ng + Block (aIL31RA) 140,00 C5a 120,00 100,00 M Co 1 10 50 100 IL-31 nAb 1 10 50 100 IL-31 + nAb 80,00 1 4 7 10 13 16 19 22 25 28 31 34 37 Tim e (seconds) 2 Raap U, Gehring M, Kasraie S. et al. Submitted. Sadaf Kasraie Division of Immunodermatology and Allergy Research 40 43 46 49 Th2 Th1 Th1 Th1 Th1 Th1 MHC II Th1 Exotoxins APC atopic dermatitis CCL2 Exotoxins TLR2 ligand IL-31RA Th2 IL-4 IL-13 IL-31 Keratinocytes Sadaf Kasraie Division of Immunodermatology and Allergy Research